| Item Type | Name |
|
Academic Article
|
Effects of fluvastatin on coronary atherosclerosis in patients with mild to moderate cholesterol elevations (Lipoprotein and Coronary Atherosclerosis Study [LCAS]).
|
|
Academic Article
|
Lipoprotein lipase gene mutations, plasma lipid levels, progression/regression of coronary atherosclerosis, response to therapy, and future clinical events. Lipoproteins and Coronary Atherosclerosis Study.
|
|
Academic Article
|
Soluble cell adhesion molecules in hypertriglyceridemia and potential significance on monocyte adhesion.
|
|
Academic Article
|
Efficacy and tolerability of fluvastatin extended-release delivery system: a pooled analysis.
|
|
Academic Article
|
Correlation of serum triglyceride and its reduction by omega-3 fatty acids with lipid transfer activity and the neutral lipid compositions of high-density and low-density lipoproteins.
|
|
Academic Article
|
The Lipoprotein and Coronary Atherosclerosis Study (LCAS): design, methods, and baseline data of a trial of fluvastatin in patients without severe hypercholesterolemia.
|
|
Academic Article
|
A variant of p22(phox), involved in generation of reactive oxygen species in the vessel wall, is associated with progression of coronary atherosclerosis.
|
|
Academic Article
|
Reducing atherothrombotic events in high-risk patients: recent data on therapy with statins and fatty acids.
|
|
Academic Article
|
Fluvastatin reduces cardiac mortality in patients with coronary heart disease.
|
|
Academic Article
|
Efficacy and safety of an extended-release formulation of fluvastatin for once-daily treatment of primary hypercholesterolemia.
|
|
Academic Article
|
Novel polymorphisms in promoter region of atp binding cassette transporter gene and plasma lipids, severity, progression, and regression of coronary atherosclerosis and response to therapy.
|
|
Academic Article
|
Combination therapy for combined dyslipidemia.
|
|
Academic Article
|
The 9p21 susceptibility locus for coronary artery disease and the severity of coronary atherosclerosis.
|
|
Academic Article
|
Marine omega-3 fatty acid intake: associations with cardiometabolic risk and response to weight loss intervention in the Look AHEAD (Action for Health in Diabetes) study.
|
|
Academic Article
|
Baseline lipoprotein lipids and low-density lipoprotein cholesterol response to prescription omega-3 acid ethyl ester added to Simvastatin therapy.
|
|
Academic Article
|
A common PCSK9 haplotype, encompassing the E670G coding single nucleotide polymorphism, is a novel genetic marker for plasma low-density lipoprotein cholesterol levels and severity of coronary atherosclerosis.
|
|
Academic Article
|
Maximizing the cost-effectiveness of lipid-lowering therapy.
|
|
Academic Article
|
Effect of moderate alcohol consumption on hypertriglyceridemia: a study in the fasting state.
|
|
Academic Article
|
Interactions between angiotensin-I converting enzyme insertion/deletion polymorphism and response of plasma lipids and coronary atherosclerosis to treatment with fluvastatin: the lipoprotein and coronary atherosclerosis study.
|
|
Academic Article
|
Apolipoprotein E genotypes and response of plasma lipids and progression-regression of coronary atherosclerosis to lipid-lowering drug therapy.
|
|
Academic Article
|
A prospective study of paraoxonase gene Q/R192 polymorphism and severity, progression and regression of coronary atherosclerosis, plasma lipid levels, clinical events and response to fluvastatin.
|
|
Academic Article
|
Effects of sirolimus on plasma lipids, lipoprotein levels, and fatty acid metabolism in renal transplant patients.
|
|
Academic Article
|
Efficacy and tolerability of fluvastatin XL 80 mg alone, ezetimibe alone, and the combination of fluvastatin XL 80 mg with ezetimibe in patients with a history of muscle-related side effects with other statins.
|
|
Academic Article
|
Increased myocardial susceptibility to repetitive ischemia with high-fat diet-induced obesity.
|
|
Concept
|
Fatty Acids, Omega-3
|
|
Concept
|
Fatty Acids, Nonesterified
|
|
Concept
|
Fatty Acids, Unsaturated
|
|
Concept
|
Fatty Acids
|
|
Concept
|
Fatty Acids, Monounsaturated
|
|
Academic Article
|
New therapeutic principles in dyslipidaemia: focus on LDL and Lp(a) lowering drugs.
|
|
Academic Article
|
Efficacy and safety of a novel dual modulator of adenosine triphosphate-citrate lyase and adenosine monophosphate-activated protein kinase in patients with hypercholesterolemia: results of a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial.
|
|
Academic Article
|
Effect of ETC-1002 on Serum Low-Density Lipoprotein Cholesterol in Hypercholesterolemic Patients Receiving Statin Therapy.
|
|
Academic Article
|
Icosapent ethyl (eicosapentaenoic acid ethyl ester): Effects on remnant-like particle cholesterol from the MARINE and ANCHOR studies.
|
|
Academic Article
|
Bempedoic Acid (ETC-1002): an Investigational Inhibitor of ATP Citrate Lyase.
|
|
Academic Article
|
Bempedoic Acid (ETC-1002): A Current Review.
|
|
Academic Article
|
Efficacy and safety of bempedoic acid added to ezetimibe in statin-intolerant patients with hypercholesterolemia: A randomized, placebo-controlled study.
|
|
Academic Article
|
Assessment of omega-3 carboxylic acids in statin-treated patients with high levels of triglycerides and low levels of high-density lipoprotein cholesterol: Rationale and design of the STRENGTH trial.
|
|
Grant
|
T Cells, Macrophages, Chemokines, and Adiposopathy in Diet-Induced Obesity
|
|
Academic Article
|
Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol.
|
|
Academic Article
|
Poststatin Lipid Therapeutics: A Review.
|
|
Academic Article
|
Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy.
|
|
Academic Article
|
Replacing Saturated Fat With Unsaturated Fat in Western Diet Reduces Foamy Monocytes and Atherosclerosis in Male Ldlr-/- Mice.
|
|
Academic Article
|
Dietary and Pharmacological Fatty Acids and Cardiovascular Health.
|
|
Academic Article
|
JCL roundtable: Omega-3 fatty acids and cardiovascular outcomes.
|
|
Academic Article
|
Bempedoic acid safety analysis: Pooled data from four phase 3 clinical trials.
|
|
Academic Article
|
Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial.
|
|
Academic Article
|
Role of Bempedoic Acid in Clinical Practice.
|
|
Academic Article
|
Association Between Omega-3 Fatty Acid Treatment and Atrial Fibrillation in Cardiovascular Outcome Trials: A Systematic Review and Meta-Analysis.
|
|
Academic Article
|
Greater than expected reduction in low-density lipoprotein-cholesterol (LDL-C) with bempedoic acid in a patient with heterozygous familial hypercholesterolemia (HeFH).
|
|
Academic Article
|
Effect of omega-3 fatty acids on cardiovascular outcomes: A systematic review and meta-analysis.
|
|
Academic Article
|
A Head-to-Head Comparison of a Free Fatty Acid Formulation of Omega-3 Pentaenoic Acids Versus Icosapent Ethyl in Adults With Hypertriglyceridemia: The ENHANCE-IT Study.
|
|
Academic Article
|
Efficacy and safety of bempedoic acid in patients not receiving statins in phase 3 clinical trials.
|
|
Academic Article
|
Long-Term Safety and Efficacy of Bempedoic Acid in Patients With Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from the CLEAR Harmony Open-Label Extension Study).
|
|
Academic Article
|
Factors Associated With Enhanced Low-Density Lipoprotein Cholesterol Lowering With Bempedoic Acid.
|
|
Academic Article
|
Omega-3 Fatty Acids and Risk for Atrial?Fibrillation: Big Fish or Small Fry?
|
|
Academic Article
|
Efficacy and safety of bempedoic acid in patients with and without metabolic syndrome: Pooled analysis of data from four phase 3 clinical trials.
|